Last reviewed · How we verify
NCT04904029
Digital Assessment Routing Tool (DART): Pilot Study
NA trial testing Digital Assessment Routing Tool [DART] in Musculoskeletal Diseases or Conditions in 78 participants. Completed in 25 July 2022.
25 July 2022
Quick facts
| Lead sponsor | Queen Mary University of London |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 78 |
| Start date | 30 May 2022 |
| Primary completion | 25 July 2022 |
| Estimated completion | 25 July 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Digital Assessment Routing Tool [DART]
- Physiotherapy-led remote triage (usual care)
Conditions studied
- Musculoskeletal Diseases or Conditions — all drugs for Musculoskeletal Diseases or Conditions →
Sponsor
Queen Mary University of London
Who can join
18 and older, any sex, with Musculoskeletal Diseases or Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the pilot study, we aim to explore trial design, assess procedures, and collect exploratory data to inform the design of a future Randomised Controlled Trial. The intervention involves a Digital Assessment Routing Tool (DART) that provides triage outcomes with recommended management pathways for participants with musculoskeletal problems. Participants complete DART either before or after their consultation with usual care clinicians (Physiotherapy-led remote triage). The triage outcome dispositions between DART and usual care clinicians will be compared. A panel will be formed to provide consensus on disagreements that may result in adverse triage outcomes, as well as on a sample of agreements between DART and usual care clinicians.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluation of a Musculoskeletal Digital Assessment Routing Tool (DART): Crossover Noninferiority Randomized Pilot Trial.
Lowe C, Sephton R, Marsh W, Morrissey D. · · 2024 · cited 2× · PMID 39078682 · DOI 10.2196/56715 -
Validation of a Musculoskeletal Digital Assessment Routing Tool: Protocol for a Pilot Randomized Crossover Noninferiority Trial.
Lowe C, Hanuman Sing H, Marsh W, Morrissey D. · · 2021 · cited 2× · PMID 34898461 · DOI 10.2196/31541
Verify or expand the search:
- PubMed search for NCT04904029
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Musculoskeletal Diseases or Conditions
Currently open trials in the same condition.
- NCT07360626 — Exercise and Health Education for Textile Workers: A Pre-Post Study · NA · recruiting
- NCT06773169 — IAMABLE: Implementation and Evaluation of an App for Evidence-Based Self-Management Rehabilitation Strategies · NA · recruiting
- NCT06838793 — ITPB 1 vs 3 in VATS · NA · recruiting
- NCT06594120 — Changes in Workability and Employment Following the Work-related Medical Rehabilitation PV RehaJET · recruiting
- NCT06488547 — Stress and Musculoskeletal Health in Employees · NA · recruiting
Other Queen Mary University of London trials
Trials by the same sponsor.
- NCT07246005 — LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus · Phase 2 · not yet recruiting
- NCT07165678 — CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2) · NA · not yet recruiting
- NCT06937372 — Delivery and Implementation of a Randomised Crossover Trial on Thrombosis · NA · not yet recruiting
- NCT06600438 — Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial · NA · not yet recruiting
- NCT06987045 — Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04904029 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen Mary University of London
- Last refreshed: 23 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04904029.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing